Clincosm LogoSign in Get a demo

ovarian cancer, epithelial

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +8 more
  • XmAb®808
  • Keytruda® (pembrolizumab)
  • Denver, Colorado
  • +2 more
Jan 19, 2023

Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

Recruiting
  • Ovarian Cancer, Epithelial
  • +14 more
  • Sutton, Surrey, United Kingdom
  • +6 more
Jul 22, 2022

Ovarian Cancer, Epithelial Trial in Nanjing (Envafolimab, Lenvatinib, VP-16)

Not yet recruiting
  • Ovarian Cancer, Epithelial
  • Nanjing, Jiangsu, China
    Zhongda Hospital
Jun 13, 2022

Ovarian Cancer, Epithelial, Peritoneal Cancer, Fallopian Tube Cancer Trial in Durham (Streamlined Education, Traditional

Completed
  • Ovarian Cancer, Epithelial
  • +2 more
  • Streamlined Education
  • Traditional Education
  • Durham, North Carolina
    Duke University Health System
Aug 25, 2021

Ovarian Cancer, Epithelial Trial in France (CC0 - Carboplatin (IV) - Paclitaxel (IV), CC0 - Cisplatin (IP) - Epirubicin (IV),

Recruiting
  • Ovarian Cancer, Epithelial
  • CC0 - Carboplatin (IV) - Paclitaxel (IV)
  • +3 more
  • Dijon, France
  • +6 more
Feb 10, 2021

Ovarian Cancer, Epithelial Ovarian Cancer, Ovarian Cancer, Epithelial Trial in Wuhan (CRS+HIPEC, CRS alone)

Recruiting
  • Ovarian Cancer
  • +4 more
  • CRS+HIPEC
  • CRS alone
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Sep 4, 2020

Ovarian Cancer, Ovary Tumor, Ovarian Tumors Trial in Wuhan (HIPEC, CRS, IVCT)

Active, not recruiting
  • Ovarian Cancer
  • +5 more
  • HIPEC
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
May 28, 2020